Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT01912651

The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery

Led by University of Michigan · Updated on 2025-03-19

300

Participants Needed

1

Research Sites

791 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Antibiotics are sometimes prescribed to patients who have had reconstructive surgery of wounds on their face using skin grafts. But, it is not yet known whether antibiotics improve the healing of skin grafts and reduce the risk of infections after surgery in these patients. It is known that antibiotics, like all medications, have side-effects although these are rare. This research study is designed to show us whether antibiotics improve wound healing or not, so that we may determine if we should continue using antibiotics even if they have side-effects in some patients. Our hypothesis is that patients treated with post-operative, systemic antibiotics will demonstrate a statistically significant improvement in the survival of their facial full thickness skin grafts compared to patients who are not treated with systemic antibiotics.

CONDITIONS

Official Title

The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults with nasal or facial skin or soft tissue defects requiring reconstruction with a full-thickness skin graft
Not Eligible

You will not qualify if you...

  • Current or recent (within one week) use of systemic antibiotics
  • Allergy or intolerance to both clindamycin and cephalexin
  • Discovery of ongoing skin cancer at the defect site after surgery
  • Previous reconstructive surgery at the defect site

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Michigan

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

Loading map...

Research Team

J

Jeffrey S Moyer, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here